MET and cancer: In previous studies and the present one, we have shown that the Met receptor can be cleaved during various physiological processes (Figure 6a).18, 21 Although many immunohistochemistry (IHC) studies have shown Met to be overexpressed in a variety of cancers,14 the Met cleavage state was never characterized in these studies.